| 6387893 |
Spirotricyclic substituted azacycloalkane derivatives and uses thereof |
Jacob M. Hoffman, Kevin F. Gilbert, Kenneth E. Rittle |
2002-05-14 |
$97,118,000 |
| 6326372 |
Lactam and cyclic urea derivatives useful as alpha 1a adrenoceptor antagonists |
Kevin F. Gilbert |
2001-12-04 |
$293,132,000 |
| 5952351 |
Alpha 1a adrenergic receptor antagonists |
Gerald S. Ponticello, Jacob M. Hoffman |
1999-09-14 |
$82,986,000 |
| 5756504 |
Tocolytic oxytocin receptor antagonists |
Mark G. Bock, J. Christopher Culberson, Kevin F. Gilbert, Kenneth E. Rittle, Peter D. Williams |
1998-05-26 |
$93,595,000 |
| 5693643 |
Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
Kevin F. Gilbert, Peter D. Williams, Doug W. Hobbs, Daniel F. Veber |
1997-12-02 |
$56,997,000 |
| 5670509 |
Tocolytic oxytocin receptor antagonists |
Douglas W. Hobbs, Joseph M. Pawluczyk, Douglas J. Pettibone, Kenneth E. Rittle, Peter D. Williams |
1997-09-23 |
$108,169,000 |
| 5665719 |
Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
Mark G. Bock, Peter D. Williams, Roger M. Freidinger, Douglas J. Pettibone, Doug W. Hobbs +1 more |
1997-09-09 |
$87,414,000 |
| 5464788 |
Tocolytic oxytocin receptor antagonists |
Mark G. Bock, J. Christopher Culberson, Kevin F. Gilbert, Kenneth E. Rittle, Peter D. Williams |
1995-11-07 |
$117,179,000 |
| 5324726 |
Benzodiazepine analogs |
Mark G. Bock, Roger M. Freidinger |
1994-06-28 |
$22,157,000 |
| 5223509 |
.beta.-carbolines as cholecystokinin and gastrin antagonists |
— |
1993-06-29 |
$38,169,000 |
| 5210082 |
2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders |
Mark G. Bock, Roger M. Freidinger |
1993-05-11 |
$39,082,000 |
| 5206234 |
Benzolactam analogs as antagonists of CCK |
Mark G. Bock, Roger M. Freidinger |
1993-04-27 |
$28,184,000 |
| 5206237 |
Benzodiazepine analogs |
Roger M. Freidinger, Mark G. Bock |
1993-04-27 |
$28,184,000 |
| 5204349 |
Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
Mark G. Bock, Roger M. Freidinger, Kevin F. Gilbert, Doug W. Hobbs, James B. Hoffman +2 more |
1993-04-20 |
$23,834,000 |
| 5185331 |
Triazolobenzodiazepines |
Roger M. Freidinger, Mark G. Bock |
1993-02-09 |
$71,020,000 |
| 5177071 |
1,4-benzodiazepines with 6-membered heterocyclic rings to treat panic and anxiety disorder |
Roger M. Freidinger, Mark G. Bock |
1993-01-05 |
$23,105,000 |
| 5175159 |
3-substituted-1,4-benzodiazepines as oxytocin antagonists |
Mark G. Bock, Roger M. Freidinger |
1992-12-29 |
$49,248,000 |
| 5166151 |
2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof |
Roger M. Freidinger, Mark G. Bock |
1992-11-24 |
$43,369,000 |
| 5091387 |
Spirocyclic oxytocin antagonists |
Douglas J. Pettibone, Roger M. Friedinger |
1992-02-25 |
$30,495,000 |
| 5004741 |
Methods of antagonizing CCK or gastrin with benzodiazepine analogs |
Mark G. Bock, Roger M. Freidinger |
1991-04-02 |
$31,133,000 |
| 4847248 |
1,4-Benzodiazepines with 5- and 6-membered heterocyclic rings and their use as cholecystokinins and gastrin antagonists |
Roger M. Freidinger, Mark G. Bock |
1989-07-11 |
$7,137,000 |
| 4820834 |
Benzodiazepine analogs |
Roger M. Freidinger, Mark G. Bock |
1989-04-11 |
$11,768,000 |
| 4812442 |
Tripeptide renin inhibitors |
Joshua S. Boger, Mark G. Bock |
1989-03-14 |
$13,397,000 |
| 4755508 |
Benzodiazepine analogs and use as antogonists of gastrin and cholecystokinin |
Mark G. Bock, Roger M. Freidinger |
1988-07-05 |
$19,352,000 |
| 4735941 |
1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as gastrointestinal and CNS agents |
Roger M. Freidinger, Mark G. Bock |
1988-04-05 |
$13,005,000 |
